Skip to content

The Optimal Temperature for Replacement Fluid and Dialysate in Continuous Renal Replacement therapy (CRRT): A randomized controlled study

The Optimal Temperature for Replacement Fluid and Dialysate in Continuous Renal Replacement therapy (CRRT): A randomized controlled study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20171117001
Enrollment
50
Registered
2017-11-17
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury requiring continuous renal replacement therapy in ICU Continuous renal replacement therapy Acute kidney injury Dialysate temperature Replacement fluid temperature

Interventions

Set dialysate/replacement fluid temperature at 37.0 degree celsius ,Set dialysate/replacement fluid temperature at 35.5 degree celsius
Active Comparator Procedure/Surgery,Experimental Procedure/Surgery
Dialysate/Replacement fluid temperature at 37C,Dialysate/Replacement fluid temperature at 35.5C

Sponsors

Renal Division, Department of Internal Medicine, Chiang Mai University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient age of more than 15 years 2. Patients who require continuous renal replacement therapy 3. Patients or relatives gave written informed consent

Exclusion criteria

Exclusion criteria: 1. Kidney transplant patients 2. Patients whom treated with slow continuous ultrafiltration (SCUF)

Design outcomes

Primary

MeasureTime frame
Stable hemodynamics 4 hours Blood pressure and norepinephrine dose

Secondary

MeasureTime frame
Stable hemodynamics 8 hours Blood pressure and norepinephrine dose,Blood lactate 8 hours Accusport, Roche Diagnostics,Death rate In hospital Percentage of patients who died

Countries

Thailand

Contacts

Public ContactKajohnsak Noppakun

Chiang Mai University

kajohnsak.noppakun@cmu.ac.th66-81-595-3465

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026